Cognitive Function in Postmenopausal Breast Cancer Patients One Year After Completing Adjuvant Endocrine Therapy With Letrozole and/or Tamoxifen in the BIG 1-98 Trial

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1235-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Design, Conduct, and Analyses of Breast International Group (BIG) 1-98: A Randomized, Double-Blind, Phase-Iii Study Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor-Positive, Early Breast Cancer

Clinical Trials
MedicinePharmacology
2009English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Trajectories of Self-Reported Cognitive Function in Postmenopausal Women During Adjuvant Systemic Therapy for Breast Cancer

Psycho-Oncology
PsychiatryMental HealthOncologyExperimentalCognitive Psychology
2015English

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2004English

Perspectives of Postmenopausal Breast Cancer Survivors on Adjuvant Endocrine Therapy-Related Symptoms

Oncology Nursing Forum
Oncology
2014English

The Relationship Between the CYP2D6 Polymorphisms and Tamoxifen Efficacy in Adjuvant Endocrine Therapy of Breast Cancer Patients in Chinese Han Population

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy